Single-Nucleus and In Situ RNA–Sequencing Reveal Cell Topographies in the Human Pancreas-Reference-Cited by-同舟云学术

Single-Nucleus and In Situ RNA–Sequencing Reveal Cell Topographies in the Human Pancreas

Published:2021-03 Issue:4 Volume:160 Page:1330-1344.e11
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Tosti Luca,Hang Yan,Debnath Olivia,Tiesmeyer Sebastian,Trefzer Timo,Steiger Katja,Ten Foo Wei,Lukassen Sören,Ballke Simone,Kühl Anja A.,Spieckermann Simone,Bottino Rita,Ishaque Naveed,Weichert Wilko,Kim Seung K.,Eils Roland,Conrad Christian

Funder

Chan Zuckerberg Initiative

European Commission

H2020 Marie Skłodowska-Curie Actions

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference53 articles.

1. Resilient ribonucleases;Farrell,2010

2. A single-cell transcriptome atlas of the human pancreas;Muraro;Cell Syst,2016

3. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure;Baron;Cell Syst,2016

4. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes;Segerstolpe;Cell Metab,2016

5. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes;Lawlor;Genome Res,2017

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer Initiation;Gastroenterology;2024-09

2. Regulatory network analysis ofDclk1gene expression reveals a tuft cell-ILC2 axis that inhibits pancreatic tumor progression;2024-08-30

3. Implementing distinct spatial proteogenomic technologies: opportunities, challenges, and key considerations;Clinical and Experimental Immunology;2024-08-12

4. A common CTRB misfolding variant associated with pancreatic cancer risk causes ER stress and inflammation in mice;2024-07-24

5. Spatial tumor immune microenvironment phenotypes in ovarian cancer;npj Precision Oncology;2024-07-18